He potential for frustration, time-wasting, and bad feelings between pharma and biotech partners is enormous. That some successful decisions are made under these circumstances is something of a miracle.
Larraine Segil
Advertisement
Articles by Larraine Segil
Advertisement
Latest Updated Articles
The Human Side of PartnershipsOctober 1st 2004
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
3
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
4
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
5